Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
12/15/2010
Trade Name:
Uroxatral
Generic or Proper Name (*):
alfuzosin
Indications Studied:
Elevated detrusor leak point pressure of neurologic origin
Therapeutic Category:
Urology
Ages Studied:
2-16 years
Study #:
3
Study Type:
Efficacy/Safety
Study Design:
Open Label
No Patients:
25
No Centers:
13
No Countries:
8
BPCA(B), PREA(P):
B
Asian:
0
Black:
0
Other:
7
White:
18
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
Countries:
(India, Maylasia, Poland, Russia, Singapore, Slovakia, Taiwan, and Turkey
-
-